Erweiterte Suche

Gegenwärtig ist Birgitte Volck SVP, Head-Clinical Development & Medical Affairs bei Ascendis Pharma A. Dr. Volck ist außerdem Mitglied des Vorstands von Soleno Therapeutics, Inc. und Vaccibody AS. Zuvor war Dr. Volck Leiterin der Forschung und Entwicklung bei GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development bei Swedish Orphan Biovitrum AB, President-Research & Development bei Avrobio, Inc, Director-Executive Development bei Amgen, Inc, Director-Nordic Medical & Project Director bei Genzyme Danmark und Head-Clinical Development & Medical Affairs bei Pharmexa A. Birgitte Volck promovierte an der Universität von Kopenhagen.

Birgitte Bonnesen served as the President & Chief Executive Officer at Swedbank AB from 2016 to 2019.
Prior to that, she worked at Swedbank AB for over 30 years.
Bonnesen holds an MBA from the Stockholm School of Economics and a graduate degree from the University of Aarhus.

Ms. Birgitte Svendsen is Chief Financial Officer at BioPorto A/S.

Birgitte Stephensen is currently working as the Chief Legal Officer & Executive Vice President at Genmab A since 2002.
She graduated from Danmarks Farmaceutiske Universitet.

Birgitte Nordvik is currently a Director at Data Design System AS.
Previously, she was a Director at Interwell AS.

Birgitte Brekke-Clifton has worked as a Director at The Salvation Army since 2013.

Birgitte Kvalevåg Øversjøen has a current job as an Analyst at DNB Bank ASA (Broker).

Birgitte Kjærgaard Sørensen is the founder of Stensgaard Holding AS, which was founded in 1994.

Birgitte Clausen currently works at Annebergs Limtræ A, as Director from 2022.

Ms. Birgitte Olsen, CFA, is a Lead Portfolio Manager at Bellevue Asset Management AG.
She is also a Senior Portfolio Manager for European Equities.
She joined the firm in 2008.
She previously spent over nine years at Generali Investments in Cologne as Deputy Head of Equities, managing European portfolios and thematic funds.

Birgitte Schou currently works at Schou Co. A, as Director and HP Schou Holding A, as Director.

Birgitte Brinch Madsen is currently the Vice Chairman at DEIF A.
She also holds several non-executive director positions, including at John Wood Group Plc, Arkil Holding A, Investeringsforeningen Danske Invest, Investeringsforeningen Danske Invest Select, and Danske Invest Select.
Previously, she worked as the Director of Energy & Industry Business at COWI A and as the Chief Technical Officer at Maersk A and Maersk FPSOs A.
She graduated from the University of Copenhagen.

Birgitte Nauntofte is currently the Vice Chairman at Steno Diabetes Center A, Director at The Danish Council For Research Policy, and a Member at Denmark Ministry of Education.
She was previously the Chief Executive Officer & Director at Novo Nordisk Fonden, Chairman at The Kennedy Collective Inc, Director at Danmarks Farmaceutiske Universitet, Professor-Clinical Oral Physiology at the University of Copenhagen, and a Member at Noregs forskingsråd and Denmark Ministry of Higher Edcation & Science.
She received her doctorate degree from the University of Copenhagen in 1993.

Birgitte Rønnow has founded Terranol A in 2007, where she currently holds the title of Chief Executive Officer.
She previously worked as a Principal at DuPont Nutrition Biosciences ApS.
Dr. Rønnow earned a doctorate degree from the University of Copenhagen in 1992.

Birgitte Skou Holck-Andersen is a Director of ACE BioSciences A/S and NatImmune A/S and Deputy Chairman of ZGene A/S.
She is an Investment Manager of A/S Dansk Erhvervsinvestering.
Dr. Holck-Andersen joined A/S Dansk Erhvervsinvestering in 2001.
She has 10 years of experience in the biotech and healthcare industries.
Dr. Holck-Andersen received an MSc degree in 1984 and a PhD in 1987 from the Technical University of Denmark.

Birgitte Lund is currently a Director at Hi3G Denmark ApS.
Previously, she was a Director at NetDesign A.

Birgitte Engebretsen is currently the Chief Executive Officer at Telenor Networks Holding AS, Telenor Norge AS, and Director at Hiddn Security AS.
She is also the Director at Telenor Maritime.
AS since 2020.
Previously, she served as an Independent Director at DNA Plc, Director at Nettverk AS, and Director-Sales & Marketing at Phonect.
AS from 2014 to 2015.

Birgitte Lundeby Kolstad has worked as a Senior Associate at HitecVision Private Equity AS since 2020 and as a Senior Financial Analyst at Copenhagen Infrastructure Partners P since 2018.

Birgitte Engleder is currently the Managing Director at Engel Gesellschaft mbH, a Member-Supervisory Board at KURIER Beteiligungs-AG, and a Managing Partner at EBS Beteiligungs GmbH.
Previously, she was an Independent Member-Supervisory Board at Oberbank AG from 2006 to 2011.